Close Menu

NEW YORK – Veravas and Tymora Analytical Operations on Monday announced a deal to "explore the integration of their respective technologies."

Specifically, the partners will enrich and measure circulating biomarkers for use in diagnostics for Alzheimer's disease, as well as other applications. Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.